Loading…

Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain

ABSTRACT Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9%...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2016-04, Vol.38 (S1), p.E588-E593
Main Authors: Bae, Dong Sik, Kim, Su-jin, Koo, Do Hoon, Paek, Se-Hyun, Kwon, Hyungju, Chai, Young Jun, Choi, June Young, Lee, Kyu Eun, Youn, Yeo-Kyu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3
cites cdi_FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3
container_end_page E593
container_issue S1
container_start_page E588
container_title Head & neck
container_volume 38
creator Bae, Dong Sik
Kim, Su-jin
Koo, Do Hoon
Paek, Se-Hyun
Kwon, Hyungju
Chai, Young Jun
Choi, June Young
Lee, Kyu Eun
Youn, Yeo-Kyu
description ABSTRACT Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9% saline (control) was instilled into the skin flap. Postoperative pain intensity (visual analog scale [VAS]), analgesic requirements (fentanyl), and adverse events were assessed at 1, 2, 4, 8, 16, and 24 hours postoperatively. Results One hundred three patients completed the study protocol. VAS scores were lower in the ropivacaine group than the control group (p = .010); however, VAS scores were not significantly different after 8 hours postoperatively. Total analgesic consumption was higher in controls than ropivacaine‐treated patients (p = .01). Adverse events did not differ between the 2 groups. Conclusion Ropivacaine instillation after robotic thyroid surgery reduces acute postoperative pain and analgesic requirements without adverse events. © 2015 Wiley Periodicals, Inc. Head Neck 38: E–E, 2016
doi_str_mv 10.1002/hed.24045
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1784745196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1784745196</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3</originalsourceid><addsrcrecordid>eNp1kE9v1DAQxS0EoqVw4AsgH0EirR3bccwNLUuLKLBI_DlajjOmhmwcbKew8OVx2C43TvM0-r03mofQQ0pOKSH12RX0pzUnXNxCx5QoWRHG5e1Fc1YxIvkRupfSV0IIa3h9Fx3VQra1ouoY_d7EkCaw2V_DUxzN2Iet_wU9tmHMMQxDkTl6M-Aw4jkBDg7HMPlrY40fARuXIZZNF7K3OF_tYvA9TnP8AnH3DK-dK9lpMU8h5TBBNMspPBX3fXTHmSHBg5t5gj6-XH9YXVSX785frZ5fVpY1TFTQtMS2TaeoaXrS1Yr3rhOmkczJVjghesO4MLxzLVVt33ZSLZLyRhljqGUn6PE-d4rh-wwp661PFobBjBDmpKlsueSCqqagT_aoLbWkCE5P0W9N3GlK9NK1Ll3rv10X9tFN7Nxty_ZAHsotwNke-OEH2P0_SV-sXxwiq73Dpww__zlM_KbLu1Loz2_P9es3n1aCbd7rDfsD84eaIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784745196</pqid></control><display><type>article</type><title>Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bae, Dong Sik ; Kim, Su-jin ; Koo, Do Hoon ; Paek, Se-Hyun ; Kwon, Hyungju ; Chai, Young Jun ; Choi, June Young ; Lee, Kyu Eun ; Youn, Yeo-Kyu</creator><creatorcontrib>Bae, Dong Sik ; Kim, Su-jin ; Koo, Do Hoon ; Paek, Se-Hyun ; Kwon, Hyungju ; Chai, Young Jun ; Choi, June Young ; Lee, Kyu Eun ; Youn, Yeo-Kyu</creatorcontrib><description>ABSTRACT Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9% saline (control) was instilled into the skin flap. Postoperative pain intensity (visual analog scale [VAS]), analgesic requirements (fentanyl), and adverse events were assessed at 1, 2, 4, 8, 16, and 24 hours postoperatively. Results One hundred three patients completed the study protocol. VAS scores were lower in the ropivacaine group than the control group (p = .010); however, VAS scores were not significantly different after 8 hours postoperatively. Total analgesic consumption was higher in controls than ropivacaine‐treated patients (p = .01). Adverse events did not differ between the 2 groups. Conclusion Ropivacaine instillation after robotic thyroid surgery reduces acute postoperative pain and analgesic requirements without adverse events. © 2015 Wiley Periodicals, Inc. Head Neck 38: E–E, 2016</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.24045</identifier><identifier>PMID: 25782919</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>acute pain ; Adult ; Amides - therapeutic use ; Analgesics - therapeutic use ; Anesthetics, Local - therapeutic use ; bilateral axillo-breast approach (BABA) ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Pain, Postoperative - drug therapy ; postoperative pain ; Prospective Studies ; Robotic Surgical Procedures ; robotic thyroid surgery ; ropivacaine ; Thyroid Gland - surgery ; Thyroid Neoplasms - surgery ; Thyroidectomy</subject><ispartof>Head &amp; neck, 2016-04, Vol.38 (S1), p.E588-E593</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3</citedby><cites>FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25782919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bae, Dong Sik</creatorcontrib><creatorcontrib>Kim, Su-jin</creatorcontrib><creatorcontrib>Koo, Do Hoon</creatorcontrib><creatorcontrib>Paek, Se-Hyun</creatorcontrib><creatorcontrib>Kwon, Hyungju</creatorcontrib><creatorcontrib>Chai, Young Jun</creatorcontrib><creatorcontrib>Choi, June Young</creatorcontrib><creatorcontrib>Lee, Kyu Eun</creatorcontrib><creatorcontrib>Youn, Yeo-Kyu</creatorcontrib><title>Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain</title><title>Head &amp; neck</title><addtitle>Head Neck</addtitle><description>ABSTRACT Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9% saline (control) was instilled into the skin flap. Postoperative pain intensity (visual analog scale [VAS]), analgesic requirements (fentanyl), and adverse events were assessed at 1, 2, 4, 8, 16, and 24 hours postoperatively. Results One hundred three patients completed the study protocol. VAS scores were lower in the ropivacaine group than the control group (p = .010); however, VAS scores were not significantly different after 8 hours postoperatively. Total analgesic consumption was higher in controls than ropivacaine‐treated patients (p = .01). Adverse events did not differ between the 2 groups. Conclusion Ropivacaine instillation after robotic thyroid surgery reduces acute postoperative pain and analgesic requirements without adverse events. © 2015 Wiley Periodicals, Inc. Head Neck 38: E–E, 2016</description><subject>acute pain</subject><subject>Adult</subject><subject>Amides - therapeutic use</subject><subject>Analgesics - therapeutic use</subject><subject>Anesthetics, Local - therapeutic use</subject><subject>bilateral axillo-breast approach (BABA)</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pain, Postoperative - drug therapy</subject><subject>postoperative pain</subject><subject>Prospective Studies</subject><subject>Robotic Surgical Procedures</subject><subject>robotic thyroid surgery</subject><subject>ropivacaine</subject><subject>Thyroid Gland - surgery</subject><subject>Thyroid Neoplasms - surgery</subject><subject>Thyroidectomy</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kE9v1DAQxS0EoqVw4AsgH0EirR3bccwNLUuLKLBI_DlajjOmhmwcbKew8OVx2C43TvM0-r03mofQQ0pOKSH12RX0pzUnXNxCx5QoWRHG5e1Fc1YxIvkRupfSV0IIa3h9Fx3VQra1ouoY_d7EkCaw2V_DUxzN2Iet_wU9tmHMMQxDkTl6M-Aw4jkBDg7HMPlrY40fARuXIZZNF7K3OF_tYvA9TnP8AnH3DK-dK9lpMU8h5TBBNMspPBX3fXTHmSHBg5t5gj6-XH9YXVSX785frZ5fVpY1TFTQtMS2TaeoaXrS1Yr3rhOmkczJVjghesO4MLxzLVVt33ZSLZLyRhljqGUn6PE-d4rh-wwp661PFobBjBDmpKlsueSCqqagT_aoLbWkCE5P0W9N3GlK9NK1Ll3rv10X9tFN7Nxty_ZAHsotwNke-OEH2P0_SV-sXxwiq73Dpww__zlM_KbLu1Loz2_P9es3n1aCbd7rDfsD84eaIA</recordid><startdate>201604</startdate><enddate>201604</enddate><creator>Bae, Dong Sik</creator><creator>Kim, Su-jin</creator><creator>Koo, Do Hoon</creator><creator>Paek, Se-Hyun</creator><creator>Kwon, Hyungju</creator><creator>Chai, Young Jun</creator><creator>Choi, June Young</creator><creator>Lee, Kyu Eun</creator><creator>Youn, Yeo-Kyu</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201604</creationdate><title>Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain</title><author>Bae, Dong Sik ; Kim, Su-jin ; Koo, Do Hoon ; Paek, Se-Hyun ; Kwon, Hyungju ; Chai, Young Jun ; Choi, June Young ; Lee, Kyu Eun ; Youn, Yeo-Kyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>acute pain</topic><topic>Adult</topic><topic>Amides - therapeutic use</topic><topic>Analgesics - therapeutic use</topic><topic>Anesthetics, Local - therapeutic use</topic><topic>bilateral axillo-breast approach (BABA)</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pain, Postoperative - drug therapy</topic><topic>postoperative pain</topic><topic>Prospective Studies</topic><topic>Robotic Surgical Procedures</topic><topic>robotic thyroid surgery</topic><topic>ropivacaine</topic><topic>Thyroid Gland - surgery</topic><topic>Thyroid Neoplasms - surgery</topic><topic>Thyroidectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bae, Dong Sik</creatorcontrib><creatorcontrib>Kim, Su-jin</creatorcontrib><creatorcontrib>Koo, Do Hoon</creatorcontrib><creatorcontrib>Paek, Se-Hyun</creatorcontrib><creatorcontrib>Kwon, Hyungju</creatorcontrib><creatorcontrib>Chai, Young Jun</creatorcontrib><creatorcontrib>Choi, June Young</creatorcontrib><creatorcontrib>Lee, Kyu Eun</creatorcontrib><creatorcontrib>Youn, Yeo-Kyu</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bae, Dong Sik</au><au>Kim, Su-jin</au><au>Koo, Do Hoon</au><au>Paek, Se-Hyun</au><au>Kwon, Hyungju</au><au>Chai, Young Jun</au><au>Choi, June Young</au><au>Lee, Kyu Eun</au><au>Youn, Yeo-Kyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain</atitle><jtitle>Head &amp; neck</jtitle><addtitle>Head Neck</addtitle><date>2016-04</date><risdate>2016</risdate><volume>38</volume><issue>S1</issue><spage>E588</spage><epage>E593</epage><pages>E588-E593</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>ABSTRACT Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9% saline (control) was instilled into the skin flap. Postoperative pain intensity (visual analog scale [VAS]), analgesic requirements (fentanyl), and adverse events were assessed at 1, 2, 4, 8, 16, and 24 hours postoperatively. Results One hundred three patients completed the study protocol. VAS scores were lower in the ropivacaine group than the control group (p = .010); however, VAS scores were not significantly different after 8 hours postoperatively. Total analgesic consumption was higher in controls than ropivacaine‐treated patients (p = .01). Adverse events did not differ between the 2 groups. Conclusion Ropivacaine instillation after robotic thyroid surgery reduces acute postoperative pain and analgesic requirements without adverse events. © 2015 Wiley Periodicals, Inc. Head Neck 38: E–E, 2016</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25782919</pmid><doi>10.1002/hed.24045</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2016-04, Vol.38 (S1), p.E588-E593
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_1784745196
source Wiley-Blackwell Read & Publish Collection
subjects acute pain
Adult
Amides - therapeutic use
Analgesics - therapeutic use
Anesthetics, Local - therapeutic use
bilateral axillo-breast approach (BABA)
Double-Blind Method
Female
Humans
Male
Middle Aged
Pain, Postoperative - drug therapy
postoperative pain
Prospective Studies
Robotic Surgical Procedures
robotic thyroid surgery
ropivacaine
Thyroid Gland - surgery
Thyroid Neoplasms - surgery
Thyroidectomy
title Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A45%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective,%20randomized%20controlled%20trial%20on%20use%20of%20ropivacaine%20after%20robotic%20thyroid%20surgery:%20Effects%20on%20postoperative%20pain&rft.jtitle=Head%20&%20neck&rft.au=Bae,%20Dong%20Sik&rft.date=2016-04&rft.volume=38&rft.issue=S1&rft.spage=E588&rft.epage=E593&rft.pages=E588-E593&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.24045&rft_dat=%3Cproquest_cross%3E1784745196%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3635-e680c86b91a6d0b294dfb5a673f785f55da345a4bf8198d8b79bf811469aaa1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1784745196&rft_id=info:pmid/25782919&rfr_iscdi=true